Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Oct 21, 2008; 14(39): 5980-5989
Published online Oct 21, 2008. doi: 10.3748/wjg.14.5980
Published online Oct 21, 2008. doi: 10.3748/wjg.14.5980
Table 2 Histological localization and involved cell type in hfgl2 positive samples
Tumor type | Case | Hfgl2 positive | Histological localization and cases | ||||
Tumor cell | CD57+ | CD3+, CD8+ | CD68+ | VWF | |||
Colon carcinoma | 21 | 21 | 19 | 20 | 18 | 21 | 17 |
Breast cancer | 20 | 20 | 18 | 20 | 20 | 20 | 18 |
Lung cancer | 22 | 20 | 18 | 20 | 19 | 20 | 18 |
Gastric cancer | 26 | 26 | 25 | 26 | 13 | 26 | 25 |
Esophageal carcinoma | 19 | 18 | 18 | 16 | 15 | 18 | 14 |
Cervix cancer | 25 | 22 | 20 | 21 | 21 | 22 | 22 |
-
Citation: Su K, Chen F, Yan WM, Zeng QL, Xu L, Xi D, Pi B, Luo XP, Ning Q. Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability
via IL-2 and IFN-γ. World J Gastroenterol 2008; 14(39): 5980-5989 - URL: https://www.wjgnet.com/1007-9327/full/v14/i39/5980.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5980